No definition available.
Disorder of pancreatic internal secretion, other and/or unspecified
DOID EFO Endpoint Browser PheWeb
E4_PANCSECNAS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
254 |
4. Check minimum number of eventsNone |
254 |
5. Include endpointsNone |
254 |
6. Filter based on genotype QC (FinnGen only) |
254 |
Control definitions (FinnGen only)
- Control exclude
- E4_GLUCOPANCREAS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorder of pancreatic internal secretion, other and/or unspecified
based on the number of shared cases.
Similar with more cases:
- Other disorders of glucose regulation and pancreatic internal secretion
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1896 | 1059 | 820 |
| Only index persons | 1511 | 896 | 615 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 44.97 | 39.12 | 52.19 |
| Only index persons | 42.06 | 36.45 | 50.25 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 254 | 161 | 93 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 41.43 | 34.97 | 52.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 232
- Matched controls
- 2319
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E16.9
ICD-10 Finland
Disorder of pancreatic internal secretion, unspecified
+∞
98.0
87
*
25109
ICD-8 Finland
Disorders of pancreatic internal secretion other than diabetes mellitus, Unspecified
+∞
63.5
58
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
17.5
49.5
82
70
A10AE04
ATC
insulin glargine; parenteral
13.4
46.1
87
99
A09AA02
ATC
multienzymes (lipase, protease etc.)
47.5
45.7
55
15
103
Kela drug reimbursment
Diabetes, insulin-treated
7.7
44.4
139
375
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
15.6
44.0
76
70
E16.89
ICD-10 Finland
Other specified disorders of pancreatic internal secretion
+∞
43.1
40
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
61.7
42.7
49
10
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
21.7
42.1
63
39
T89
ICPC
Diabetes insulin dependent
28.6
41.8
57
26
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
30.9
41.2
55
23
A10AA02
ATC
NA
27.6
37.8
52
24
215
Kela drug reimbursment
Diabetes, non-insulin-treated
6.6
37.0
124
342
A10AE05
ATC
insulin detemir; parenteral
15.9
36.7
62
52
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
33.4
35.4
46
17
A10AA01
ATC
NA
29.0
31.9
43
18
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
29.0
30.5
41
17
H04AA01
ATC
glucagon; nasal, parenteral
28.1
28.1
38
16
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
26.4
27.6
38
17
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
110.0
27.3
29
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
18.7
27.2
42
27
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
34.7
25.8
33
11
A10AE06
ATC
insulin degludec; parenteral
21.8
25.3
37
20
H3603, E103
ICD-10 Finland
NA
44.3
19.9
24
6
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
34.8
19.7
25
8
E10
ICD-10 Finland
Type 1 diabetes mellitus
21.0
19.2
28
15
E16.19
ICD-10 Finland
Other specified hypoglycaemia
+∞
19.0
18
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
4.1
18.8
89
304
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
46.0
17.6
21
5
SPAT1262
SPAT
Handing over of treatment supplies
4.2
17.6
77
243
T90
ICPC
Diabetes non-insulin dependent
3.9
16.5
82
287
XCK10
NOMESCO Finland
Photography of fundus of eye
5.4
16.5
53
120
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
38.8
14.7
18
5
H3600, E103
ICD-10 Finland
NA
24.2
14.5
20
9
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
45.7
14.3
17
*
2518X
ICD-9 Finland
Other disorders of pancreatic internal secretion, Other specified disorders of pancreatic internal secretion
+∞
13.7
13
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
30.4
13.2
17
6
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
30.4
13.2
17
6
E16.85
ICD-10 Finland
Zollinger-Ellison syndrome
+∞
12.6
12
*
A10BA02
ATC
metformin; oral
3.1
12.6
88
384
25108
ICD-8 Finland
Disorders of pancreatic internal secretion other than diabetes mellitus, Alia definita
+∞
11.6
11
*
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
+∞
11.6
11
*
H3601, E103
ICD-10 Finland
NA
126.0
11.5
12
*
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
14.9
11.2
18
13
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
10.9
51
164
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.2
10.9
26
40
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
29.6
10.9
14
5
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
13.8
10.8
18
14
2519X
ICD-9 Finland
Other disorders of pancreatic internal secretion, Unspecified disorder of pancreatic internal secretion
+∞
10.5
10
*
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
42.0
10.1
12
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
27.4
9.9
13
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
9.6
49
168
E16.80
ICD-10 Finland
Hypergastrinaemia
+∞
9.4
9
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
12.2
9.2
16
14
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
38.3
9.1
11
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
25.2
9.0
12
5
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
13.3
9.0
15
12
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
9.2
9.0
18
21
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
52.0
8.7
10
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.5
8.7
22
37
ZXA00
NOMESCO Finland
Right side
2.5
8.5
79
395
K86.1
ICD-10 Finland
Other chronic pancreatitis
13.4
8.5
14
11
RJ410
NOMESCO Finland
NA
93.3
8.5
9
*
RJ420
NOMESCO Finland
NA
93.3
8.5
9
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.1
8.5
17
20
B81
ICPC
Anaemia vit B12/folate deficiency
9.1
8.5
17
20
TK800
NOMESCO Finland
Hemodialysis
11.4
8.4
15
14
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.5
8.4
78
389
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
8.4
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
8.4
80
406
C03CA01
ATC
furosemide; systemic
2.5
8.2
73
357
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
34.7
8.1
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.0
8.1
49
189
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
23.0
8.1
11
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.8
8.1
22
41
CKC10
NOMESCO Finland
Local photocoagulation of retina
13.7
8.0
13
10
CKC12
NOMESCO Finland
Photocoagulation of retina
5.7
7.9
22
42
B03BA03
ATC
hydroxocobalamin; parenteral
6.0
7.9
21
38
Y6099
ICD-8 Finland
Prenatal care and observation
4.7
7.8
26
61
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
15.7
7.8
12
8
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.3
7.7
15
17
R4110
NOMESCO Finland
Physiotherapy
2.4
7.6
77
400
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
+∞
7.3
7
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
7.3
52
222
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
7.7
7.3
16
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
7.2
31
93
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
7.2
23
52
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
20.8
7.2
10
5
A10AA03
ATC
NA
20.8
7.2
10
5
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.3
7.2
21
43
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
5.5
7.1
20
39
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
7.0
60
283
A10BB12
ATC
glimepiride; oral
4.3
7.0
25
63
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.9
7.0
46
185
H3601, E113
ICD-10 Finland
NA
14.4
7.0
11
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.9
107
664
H36.01
ICD-10 Finland
Diabetic maculopathy
41.3
6.8
8
*
E13
ICD-10 Finland
Other specified diabetes mellitus
41.3
6.8
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.0
6.7
26
71
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
23.3
6.7
9
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
12.8
6.6
11
9
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
7.8
6.5
14
19
RJ421
NOMESCO Finland
NA
71.7
6.5
7
*
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
71.7
6.5
7
*
A12AA04
ATC
calcium carbonate; oral
14.8
6.5
10
7
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
6.4
33
115
WX002
NOMESCO Finland
Sedation and analgesia
2.4
6.4
56
268
127
Kela drug reimbursment
Transplant complication
18.6
6.3
9
5
E16.10
ICD-10 Finland
Hyperinsulinism
+∞
6.3
6
*
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
6.1
6.3
16
28
Z94.0
ICD-10 Finland
Kidney transplant status
27.5
6.3
8
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
27.5
6.3
8
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.4
6.3
29
93
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
6.2
35
129
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
6.2
61
309
NHQ40
NOMESCO Finland
Amputation of toe
13.0
6.1
10
8
L04AA06
ATC
mycophenolic acid; systemic
13.0
6.1
10
8
H43.1
ICD-10 Finland
Vitreous haemorrhage
7.0
6.1
14
21
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
9.0
6.1
12
14
205
Kela drug reimbursment
Chronic hypertension
2.2
6.1
68
361
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
10.4
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000570) Elastase.pancreatic [Mass/mass] in Stool
50
65
9.33
37.54
2.0
1.4
ug/g
159.9
303.7
3.63
27
38
(3012516) Albumin [Mass/volume] in Urine
133
569
3.81
24.70
5.3
3.2
mg/l
38.6
173.6
0.63
100
364
(3009508) Creatinine [Moles/volume] in Urine
136
607
3.67
23.35
5.3
3.2
mmol/l
6.8
7.6
1.10
120
510
(3020682) Albumin/Creatinine [Ratio] in Urine
134
601
3.60
22.67
6.6
3.9
mg/mmol
7.4
8.5
0.16
96
374
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
49
7.07
19.31
2.2
1.4
nmol/l
0.6
0.9
0.60
23
42
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
156
4.03
16.28
6.6
3.8
ng/l
94.3
74.3
1.02
44
142
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
19
24
8.48
14.21
5.2
3.7
nmol/l
37.3
2.8
0.97
19
24
(3024561) Albumin [Mass/volume] in Serum or Plasma
147
850
2.73
13.78
7.7
4.6
g/l
34.0
36.1
4.21
139
803
(3036481) Cortisol [Moles/volume] in Serum or Plasma
57
198
3.42
13.57
1.9
1.9
nmol/l
436.8
365.5
1.84
51
184
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
263
3.10
13.01
3.9
2.3
%
21.8
22.7
0.16
60
226
(3007853) Bacteria identified in Skin by Aerobe culture
56
223
2.94
10.43
3.0
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
89
450
2.51
10.35
1.7
1.5
nmol/l
23.2
21.5
0.55
70
377
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
144
903
2.37
10.30
13.9
6.2
mmol/l
1.2
1.2
0.01
134
824
(3026782) Osmolality of Urine
81
396
2.53
10.08
4.2
2.7
mosm/kgh2o
466.1
546.6
3.46
71
344
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
134
3.36
9.95
2.3
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
152
986
2.35
9.91
16.0
7.0
mmol/l
1.2
1.2
0.06
129
842
(3000991) Gas panel - Venous blood
44
158
3.16
9.77
12.7
8.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
88
463
2.38
9.21
3.4
2.1
mg/l
2.9
3.1
0.23
79
402
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
136
866
2.23
8.96
3.8
2.3
nmol/l
75.5
77.9
0.39
128
766
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
18
7.56
8.93
1.2
1.2
u/l
62.7
93.6
—
7
11
(42870588) Differential panel, method unspecified - Blood
113
669
2.24
8.89
9.0
5.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
93
511
2.29
8.73
7.3
3.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
107
624
2.23
8.69
5.7
3.2
e6/l
62.4
49.2
0.11
89
477
(3012544) pH of Venous blood
45
175
2.91
8.67
9.4
4.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
99
562
2.25
8.57
5.3
3.0
e6/l
0.2
0.4
1.02
79
419
(3000850) Epithelial cells [#/volume] in Urine
82
431
2.33
8.51
4.1
2.5
e6/l
10.3
4.7
1.12
73
385
(3015377) Calcium [Moles/volume] in Serum or Plasma
115
698
2.18
8.39
3.5
3.3
mmol/l
2.4
2.4
0.01
100
604
(3002032) Base excess in Venous blood by calculation
44
175
2.83
8.12
9.7
4.2
mmol/l
1.7
2.2
0.48
37
134
(3021447) Carbon dioxide [Partial pressure] in Venous blood
44
176
2.81
8.03
9.6
4.2
kpa
6.0
5.9
0.45
39
171
(3018677) aPTT in Platelet poor plasma by Coagulation assay
62
301
2.40
7.61
2.6
2.0
s
28.8
29.4
0.53
62
294
(3013826) Glucose [Moles/volume] in Serum or Plasma
166
1192
2.13
7.51
11.4
4.9
mmol/l
8.5
6.6
9.77
160
1102
(3018095) Leukocytes [#/volume] in Urine
116
730
2.08
7.49
7.0
3.7
e6/l
67.1
52.9
0.22
90
514
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
122
784
2.07
7.43
3.1
1.9
pmol/l
92.0
97.1
0.37
65
383
(3026008) Bacteria identified in Urine by Culture
101
605
2.11
7.42
4.9
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
46
4.38
7.41
3.6
3.0
u/ml
0.3
0.3
0.55
11
24
(3018418) pH of Serum or Plasma
102
614
2.10
7.39
7.9
3.8
ph
7.4
7.4
0.49
19
111
(3032080) INR in Blood by Coagulation assay
119
759
2.07
7.38
7.8
8.6
inr
1.2
1.2
0.02
35
215
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
116
733
2.07
7.38
6.2
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
463
2.18
7.31
1.6
1.8
mg/l
1.1
1.4
0.39
67
360
(4146454)
11
16
7.14
7.21
4.1
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
105
646
2.07
7.12
4.0
2.4
u/l
46.8
56.5
2.03
96
588
(36304419) Bacteria [Presence] in Urine
94
555
2.10
7.12
5.5
2.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
138
938
2.03
7.10
9.4
5.6
%
0.7
0.7
0.19
131
870
(3003396) Base excess in Arterial blood by calculation
46
204
2.53
6.82
8.4
10.3
mmol/l
1.5
1.2
0.15
37
166
(3019309) Folate [Moles/volume] in Red Blood Cells
65
339
2.23
6.69
2.0
1.7
nmol/l
1139.2
1244.1
0.41
51
258
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
17
41
4.37
6.66
1.2
1.1
iu/ml
1.2
2.5
—
6
6
(3042936) Bacteria identified in Isolate by Culture
57
283
2.31
6.59
3.9
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
25
5.43
6.56
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
29
5.05
6.53
1.4
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
45
205
2.45
6.29
2.2
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
138
965
1.94
6.27
9.7
5.6
%
3.1
2.8
1.24
131
894
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
296
2.24
6.26
2.5
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
53
3.79
6.16
1.4
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
138
969
1.93
6.15
10.2
6.0
%
8.7
8.5
0.41
131
906
(3002030) Lymphocytes/100 leukocytes in Blood
140
988
1.93
6.14
9.8
5.8
%
27.3
28.9
0.90
134
919
(3014576) Chloride [Moles/volume] in Serum or Plasma
48
230
2.34
5.99
11.8
7.0
mmol/l
104.4
103.6
0.56
48
223
(3024928) Oxygen saturation in Venous blood
15
36
4.37
5.91
3.5
4.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
34
140
2.65
5.83
2.2
2.7
e9/l
65.8
70.2
0.48
23
105
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
312
2.16
5.81
5.2
3.0
e6/l
3.3
2.8
0.11
34
164
(3019198) Lymphocytes [#/volume] in Blood
145
1049
1.89
5.76
9.2
5.7
e9/l
1.9
2.1
0.47
122
936
(3013115) Eosinophils [#/volume] in Blood
146
1062
1.88
5.67
9.7
5.9
e9/l
0.2
0.2
1.61
122
941
(3001604) Monocytes [#/volume] in Blood
142
1024
1.88
5.67
9.1
5.6
e9/l
0.6
0.6
1.61
118
891
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
7
13.27
5.62
3.9
4.6
umol/l
17.7
29.3
—
9
7
(3006315) Basophils [#/volume] in Blood
142
1027
1.87
5.58
9.1
5.7
e9/l
0.0
0.0
0.72
118
898
(3018010) Neutrophils/100 leukocytes in Blood
137
981
1.86
5.55
9.9
5.5
%
57.3
56.5
0.32
132
923
(3013650) Neutrophils [#/volume] in Blood by Automated count
160
1209
1.87
5.40
14.2
9.0
e9/l
4.1
4.0
0.43
135
1064
(3051611) Lipemic interference index of Serum or Plasma
10
19
5.44
5.08
2.8
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
178
1410
1.88
4.97
7.4
4.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
84
532
1.87
4.90
10.5
7.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
121
857
1.79
4.88
4.4
2.7
ug/l
114.3
107.1
0.19
116
789
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
24
4.75
4.83
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
71
429
1.91
4.77
1.7
1.4
g/l
2.5
2.4
0.16
40
246
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
104
2.67
4.72
1.9
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
38
3.84
4.71
2.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
38
3.84
4.71
2.1
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
210
2.20
4.71
2.5
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
455
1.88
4.71
3.8
2.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
145
1093
1.76
4.64
8.2
5.9
umol/l
9.1
11.2
3.01
138
1029
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
63
369
1.94
4.63
5.0
3.5
ng/l
136.2
308.7
0.64
44
282
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
62
363
1.94
4.55
2.8
2.8
mmol/l
2.5
2.5
0.74
52
315
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
106
2.62
4.55
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
51
279
2.04
4.54
2.6
2.3
ug/g
191.0
109.5
0.80
42
222
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
78
494
1.84
4.50
1.8
1.3
u/ml
1.0
1.2
0.11
20
139
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
45
237
2.09
4.42
3.1
2.8
umol/l
5.7
6.2
0.14
40
209
(3017143) Hepatitis C virus Ab [Presence] in Serum
42
218
2.11
4.28
2.0
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
13
36
3.75
4.26
2.2
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
389
1.86
4.17
1.8
1.8
pmol/l
466.6
455.4
0.11
54
330
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
89
598
1.75
4.16
3.2
2.2
u/l
162.3
215.4
0.49
81
565
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
41
216
2.07
4.02
3.0
2.2
u/l
20.9
28.7
1.49
34
181
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
60
2.96
3.87
1.6
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
9
15
6.18
3.85
3.2
4.1
mu/l
10.4
59.2
—
9
15
(1616796) Gas panel - Central venous blood
13
39
3.46
3.81
6.2
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
39
3.46
3.81
2.2
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
33
163
2.18
3.81
9.0
7.5
mmol/l
1.3
1.4
0.17
33
158
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
23
97
2.51
3.77
7.7
14.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
90
621
1.70
3.76
3.9
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
50
3.13
3.75
2.2
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
43
237
1.98
3.73
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
83
562
1.71
3.71
2.0
1.7
mmol/l
1.3
1.4
0.32
72
469
(3004588) Protein electrophoresis panel - Serum or Plasma
25
111
2.39
3.69
4.5
2.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
138
2.24
3.66
1.4
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
340
1.83
3.63
4.9
2.8
e6/l
1.3
1.0
0.20
30
189
(3021589) Normoblasts [#/volume] in Blood
124
939
1.63
3.57
15.9
8.8
e9/l
0.0
0.0
0.98
95
772
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
204
2.01
3.54
4.5
3.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
6
10.20
3.51
1.0
1.0
miu/ml
1507.8
1739.5
—
6
6
(3051593) INR in Capillary blood by Coagulation assay
6
6
10.20
3.51
2.3
9.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
41
227
1.96
3.51
12.7
18.4
inr
1.0
1.3
—
5
35
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
122
2.26
3.40
17.8
4.2
mmol/l
0.7
1.4
0.48
18
95
(3052851) Hemolysis interference index of Serum or Plasma
16
60
2.78
3.29
4.1
2.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
7
8.74
3.28
1.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
7
8.74
3.28
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
48
287
1.83
3.26
1.5
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
15
5.47
3.21
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
39
3.18
3.13
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
39
3.18
3.13
1.7
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
74
506
1.65
3.12
3.7
2.7
umol/l
4167.1
7181.0
0.31
66
436
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
62
2.69
3.11
6.2
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
8
7.65
3.07
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
40
3.10
3.01
2.9
3.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
9
6.79
2.88
1.0
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
78
2.41
2.82
1.9
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
186
1603
1.60
2.77
12.6
7.0
u/l
90.7
78.3
2.14
181
1488
(40768446) Kidney Pathology biopsy report
5
6
8.47
2.76
3.4
1.5
—
—
—
0
0
(4062490)
8
19
4.31
2.70
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
281
1.73
2.64
1.9
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
38
2.98
2.61
1.7
1.5
u/ml
324.0
268.1
—
5
20
(3044889) 12 lead EKG panel
167
1415
1.53
2.59
4.7
3.7
—
—
—
0
0
(4035726)
32
181
1.88
2.58
1.4
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.26
2.56
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
11
5.56
2.56
1.2
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
26
3.55
2.50
1.9
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
239
1.75
2.44
1.9
1.8
%
1.8
1.5
0.53
31
209
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
202
0.38
2.42
1.9
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
22
3.72
2.38
2.0
2.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
8
6.35
2.38
1.2
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
17
4.20
2.37
1.3
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
120
2.01
2.34
8.3
8.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
332
1.63
2.33
2.2
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
28
3.29
2.33
1.3
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
23
3.56
2.29
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
9
5.64
2.22
3.8
3.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.64
2.22
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
126
1034
1.43
2.13
5.1
3.6
estimate
0.0
0.0
0.50
23
188
(3021601) Nitrite [Presence] in Urine by Test strip
125
1025
1.43
2.12
7.2
4.8
estimate
0.0
0.0
0.00
29
193
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
25
3.27
2.11
1.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
17
83
2.12
2.06
3.6
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
124
1019
1.42
2.06
5.0
3.6
estimate
0.0
0.0
0.00
25
194
(3000034) Microalbumin [Mass/volume] in Urine
6
15
4.07
2.05
3.0
2.7
mg/l
27.3
24.1
—
6
10
(3051651) Icteric interference index of Serum or Plasma
6
15
4.07
2.05
2.0
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
38
2.70
2.03
2.4
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
8
26
3.14
2.03
2.8
3.7
umol/l
14.0
14.7
—
8
18
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
26
3.14
2.03
1.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
45
2.51
1.96
1.2
2.1
—
—
—
0
0
(3004451) EKG impression Narrative
5
11
4.61
1.95
1.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
22
3.24
1.89
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
28
2.92
1.88
4.4
4.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
21
116
1.88
1.85
13.3
9.1
%
1.8
1.4
0.49
21
116
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
17
3.59
1.85
1.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
12
4.23
1.83
1.4
1.2
mmol/l
2.1
1.8
—
5
12
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
12
4.23
1.83
1.4
4.8
%
113.0
82.8
—
5
12
(3019225) pH of Specimen
29
179
1.70
1.79
7.8
4.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
209
1913
1.52
1.79
12.3
5.6
mmol/mol
51.1
39.6
17.74
198
1787
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
74
566
1.43
1.78
3.0
3.2
ng/l
1743.0
1036.1
0.66
64
478
(3021387) Prolactin [Units/volume] in Serum or Plasma
13
61
2.19
1.74
3.4
1.6
mu/l
469.9
291.1
0.51
13
55
(3022313) Gas panel - Capillary blood
18
97
1.92
1.71
21.4
4.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
11
49
2.30
1.66
6.9
4.8
—
4.3
—
0
5
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
32
2.55
1.61
3.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
32
2.55
1.61
3.6
1.5
—
—
—
0
0
(44790047)
7
26
2.74
1.59
3.7
1.8
—
—
—
0
0
(44790049)
7
26
2.74
1.59
3.7
1.8
—
—
—
0
0
(44790048)
7
26
2.74
1.59
3.7
1.8
—
—
—
0
0
(44806118)
7
26
2.74
1.59
3.7
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
33
2.47
1.55
1.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
186
2015
0.71
1.54
6.7
4.5
mmol/l
7.1
5.9
8.15
168
1853
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
42
0.00
1.54
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
42
0.00
1.54
0.0
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
20
116
1.79
1.54
13.7
9.1
%
0.7
0.7
0.01
20
116
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
43
0.00
1.53
0.0
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
5
15
3.38
1.53
3.8
2.4
e9/l
3.0
1.1
—
5
5
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
15
3.38
1.53
1.8
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
27
2.64
1.52
1.3
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
65
2.05
1.51
1.8
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
21
2.90
1.51
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
21
2.90
1.51
1.7
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
92
751
1.35
1.48
5.0
3.6
ng/l
31.2
40.2
0.50
71
499
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
211
0.50
1.46
1.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
28
2.54
1.46
1.3
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
28
2.54
1.46
1.3
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
16
3.17
1.44
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
16
3.17
1.44
1.4
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
22
2.77
1.44
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
486
1.39
1.43
4.2
3.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
40
2.29
1.41
1.6
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
40
2.29
1.41
1.9
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
24
151
1.65
1.41
2.0
2.5
—
18.1
—
0
5
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
29
2.45
1.40
1.3
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
9
41
2.24
1.38
1.3
1.2
mmol/l
4.5
3.6
—
9
35
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
41
2.24
1.38
2.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
71
562
1.37
1.38
4.5
3.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.65
1.37
2.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
35
243
1.51
1.37
1.9
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
17
2.98
1.36
1.6
3.2
ug/l
54.3
17.0
—
5
17
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
112
951
1.32
1.36
5.0
4.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
68
1.96
1.36
2.5
3.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
24
2.54
1.31
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
55
2.05
1.29
2.7
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
18
2.81
1.29
1.8
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
22
139
1.64
1.28
3.1
2.4
e9/l
4.7
3.8
0.78
16
113
(40760888) Immunoglobulin light chains.free panel - Serum
8
37
2.20
1.22
4.3
5.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
109
1.70
1.22
2.6
2.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
19
2.66
1.22
1.8
1.6
pg
29.2
32.9
—
5
19
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
206
1921
1.38
1.21
7.3
4.8
mu/l
2.0
1.9
0.04
193
1760
(3025941) Bacteria identified in Stool by Culture
19
119
1.64
1.15
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
26
177
1.52
1.13
5.9
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
51
2.00
1.13
5.9
2.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
21
2.41
1.09
4.6
1.3
%
87.1
90.6
—
5
21
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
32
2.22
1.09
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
74
1.80
1.09
2.3
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
52
1.96
1.07
3.4
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
19
122
1.60
1.06
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
409
0.70
1.05
1.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
22
2.30
1.04
2.0
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
34
2.09
1.03
2.7
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
47
1.95
1.03
1.3
1.3
mg/l
666.3
446.5
—
9
42
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
68
1.80
1.02
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
22
148
1.53
1.02
3.1
4.1
%
0.0
0.3
—
5
31
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
76
1.75
1.01
1.8
1.5
—
—
—
0
0
(3013512) EKG study
70
579
1.29
0.99
5.9
3.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
16
100
1.64
0.99
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
23
2.20
0.98
1.2
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
36
1.97
0.98
2.4
3.2
%
59.0
61.5
—
7
36
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
62
1.81
0.95
1.5
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
20
134
1.53
0.95
3.6
2.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
37
1.92
0.95
1.0
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
37
1.92
0.95
2.9
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
27
2.25
0.94
1.8
2.1
—
—
—
0
0
(4306422)
6
27
2.25
0.94
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
177
1.46
0.92
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
152
1.49
0.91
1.1
1.2
iu/ml
169.9
152.2
—
7
60
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
30
2.02
0.87
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
30
2.02
0.87
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
30
2.02
0.87
6.3
2.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
30
2.02
0.87
1.2
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
21
146
1.48
0.85
3.2
4.3
%
0.0
0.0
—
7
36
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
153
1403
1.23
0.84
5.2
3.0
u/l
74.5
45.0
2.14
141
1309
(3021440) Promyelocytes/100 leukocytes in Blood
22
155
1.46
0.84
3.1
4.2
%
0.2
0.2
—
6
44
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
74
1.65
0.79
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
74
1.65
0.79
1.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
33
254
1.34
0.78
1.2
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
75
1.63
0.76
1.4
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
168
1565
1.22
0.75
6.1
4.0
mm/h
15.9
11.3
2.82
157
1422
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
2.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
2.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
24
2.10
0.75
2.2
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
56
467
1.26
0.75
4.1
3.9
kg/l
1.0
1.0
0.43
12
59
(3017181) Myelocytes/100 leukocytes in Blood
23
168
1.41
0.74
3.0
4.1
%
0.5
0.8
—
6
50
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
3.0
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
66
766
0.81
0.72
3.3
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
42
1.69
0.69
1.4
1.4
e6/l
2.1
236.9
—
7
33
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
42
1.69
0.69
1.4
1.3
e6/l
77.0
3.5
—
7
31
(3000492) Spirometry study
24
180
1.37
0.68
1.5
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
172
1615
1.20
0.67
6.0
4.0
pmol/l
14.9
14.7
0.61
162
1466
(3000963) Hemoglobin [Mass/volume] in Blood
226
2324
0.75
0.67
44.3
19.3
g/l
129.4
135.7
7.56
226
2289
(3035941) MCH [Entitic mass]
226
2322
0.76
0.63
43.8
19.2
pg
30.0
30.3
1.56
226
2288
(3026361) Erythrocytes [#/volume] in Blood
226
2322
0.76
0.63
44.0
19.3
e12/l
4.4
4.5
3.15
220
2258
(3010813) Leukocytes [#/volume] in Blood
226
2322
0.76
0.63
43.9
19.3
e9/l
7.2
6.7
3.51
220
2261
(3024731) MCV [Entitic volume]
226
2321
0.76
0.62
43.8
19.2
fl
90.7
90.9
0.27
226
2287
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
30
1.68
0.61
1.2
1.1
u/ml
—
1.4
—
0
11
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
206
1975
1.23
0.60
5.2
4.0
mmol/l
1.4
1.3
0.46
188
1822
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
202
1934
1.22
0.59
25.9
12.0
ml/min/173m2
80.4
81.7
0.30
169
1573
(1002224) Polysomnography panel
12
81
1.51
0.58
1.2
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
36
1.68
0.57
2.5
2.7
e9/l
4.8
5.0
—
6
36
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
217
2095
1.25
0.57
30.5
13.1
mg/l
25.4
21.9
0.88
186
1609
(40768443) Skin Pathology biopsy report
13
91
1.45
0.54
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
353
1.23
0.54
1.2
1.3
iu/ml
29.9
26.8
0.08
12
116
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
64
1.42
0.52
1.4
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
201
0.73
0.51
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
354
0.80
0.51
1.3
1.4
—
—
—
0
0
(4010399)
20
154
1.32
0.50
1.3
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
45
1.57
0.49
3.0
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
47
1.50
0.48
2.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
68
1.49
0.47
2.8
1.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
48
1.47
0.47
4.6
3.5
u/ml
15.4
31.4
—
7
48
(40768804) Tissue Pathology biopsy report
91
831
1.15
0.46
2.3
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
51
1.38
0.44
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
31
1.62
0.43
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
96
1.37
0.42
2.0
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
102
0.68
0.40
1.1
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
35
1.44
0.39
8.0
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
197
1.24
0.39
2.2
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
68
1.34
0.38
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
37
1.36
0.37
1.6
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
3.8
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
215
2095
1.17
0.36
6.9
4.9
mmol/l
2.3
2.8
12.31
202
1936
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
87
804
1.12
0.36
4.7
3.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
51
568
0.87
0.35
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
390
0.85
0.34
3.4
4.2
%
19.7
20.5
0.12
13
176
(3011288) Drugs identified in Urine by Screen method
6
45
1.34
0.34
2.3
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
101
1.30
0.32
2.6
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
141
1350
1.10
0.29
3.1
3.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
194
1890
1.11
0.27
33.3
14.0
%
38.0
40.0
2.17
150
1412
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
254
1.16
0.26
6.5
4.3
%
33.4
31.8
0.30
21
167
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
74
0.67
0.26
1.6
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
174
1788
0.91
0.24
39.7
17.1
g/l
329.6
332.3
3.00
174
1779
(3029937) Albumin [Presence] in Urine by Test strip
61
567
1.10
0.23
5.4
3.8
estimate
0.0
0.0
0.00
28
191
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
293
0.87
0.22
2.7
2.7
ug/l
0.6
0.7
0.48
20
178
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.7
—
12.5
—
0
11
(3045788) Cell count panel - Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
4.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.4
—
11.3
—
0
10
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
7.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
13
0.00
0.21
0.0
1.3
—
233.3
—
0
13
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.3
—
15870.0
—
0
7
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
48
1.26
0.20
2.7
1.9
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.3
—
2502.7
—
0
9
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
241
1.13
0.20
11.8
6.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
51
1.18
0.19
1.7
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
53
1.14
0.19
1.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
53
1.14
0.19
1.2
1.4
—
2.2
—
0
11
(1761482) Bacteria [#/volume] in Urine by Culture
7
58
1.21
0.18
2.0
4.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
60
1.17
0.18
1.6
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
60
1.17
0.18
16.6
3.1
mmol/l
3.9
4.0
—
7
55
(3016879) Cocaine [Presence] in Urine
7
60
1.17
0.18
1.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
61
1.15
0.17
1.6
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
62
1.13
0.17
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
62
1.13
0.17
1.6
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
66
0.75
0.17
1.2
1.3
—
2.0
—
0
5
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
208
2048
1.09
0.16
6.0
4.4
mmol/l
1.4
1.5
1.86
193
1894
(3019832) Treponema pallidum Ab [Presence] in Serum
15
172
0.86
0.16
2.0
1.6
—
—
—
0
0
(3020891) Body temperature
9
79
1.14
0.15
19.6
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
24
220
1.10
0.12
2.4
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
114
1.15
0.12
1.0
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
45
475
0.94
0.12
5.5
4.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
163
1.11
0.11
3.3
2.5
ml/min/173m2
55.5
66.5
—
6
67
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
47
1.07
0.09
1.2
1.3
—
42.2
—
0
7
(40761511) CBC panel - Blood by Automated count
219
2171
1.06
0.09
28.4
12.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
54
1.11
0.09
1.2
1.4
—
8.8
—
0
13
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
347
0.94
0.08
1.3
1.3
u/ml
29.9
8.4
0.53
13
134
(4034850)
6
73
0.82
0.07
16.5
9.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
80
0.87
0.07
1.1
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
178
1.07
0.06
5.5
3.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
207
2058
1.03
0.04
6.0
4.5
mmol/l
4.2
4.7
10.00
192
1912
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
222
2212
1.03
0.02
18.0
10.1
u/l
27.2
26.3
0.32
217
2124
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
117
0.94
0.02
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
213
0.98
0.00
2.0
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
61
0.98
0.00
1.3
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
225.9
—
0
9
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
158.8
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
9.3
—
0
9
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
14.5
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.3
—
0
6
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
11.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
34.9
—
0
6
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.6
—
5.2
—
0
5
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_PANCSECNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PANCSECNAS | 2.933 [2.09, 4.12] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.055 |
During the follow-up period (1.1.1998 — 31.12.2019), 166 out of 473 females with E4_PANCSECNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PANCSECNAS | 4.546 [3.15, 6.57] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 229 out of 479 males with E4_PANCSECNAS died.
Mortality risk
Mortality risk for people of age
years, who have E4_PANCSECNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.191% | 0.945% |
| 5 | 1.541% | 5.339% |
| 10 | 4.135% | 12.739% |
| 15 | 7.215% | 22.267% |
| 20 | 12.337% | 36.003% |
Relationships between endpoints
↥Index endpoint: E4_PANCSECNAS – Disorder of pancreatic internal secretion, other and/or unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data